Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000009:adverse effects; D004961:Estramustine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011897:Random Allocation; D013997:Time Factors; D014922:Wisconsin
D009588:Nitrogen Mustard Compounds; D004961:Estramustine; D004054:Diethylstilbestrol